Novel synthetic benzimidazole-derived oligosaccharide, M3BIM, prevents ex vivo platelet aggregation and in vivo thromboembolism

Pharmacology, Toxicology and Pharmaceutical Science

• Antiplatelet 100%
• Thromboembolism 100%
• Benzimidazole 100%
• Oligosaccharide 100%
• Mouse 66%
• Protein Kinase C 66%
• Cardiovascular Disease 33%
• Cytotoxicity 33%
• Phosphotransferase 33%
• Mitogen Activated Protein Kinase 33%
• Zebra Fish 33%
• Prothrombin 33%
• Mitogen Activated Protein Kinase 1 33%
• Clinical Feature 33%
• Thrombin 33%
• Thrombus 33%
• Brain Infarction 33%
• Acetylsalicylic Acid 33%
• Anticoagulant Agent 33%
• Antithrombotic Activity 33%
• Antithrombocytic Agent 33%
• Phorbol 12,13-dibutyrate 33%
• Phospholipase 33%
• Clopidogrel 33%
• Anticoagulant Activity 33%
• Disease 33%
• Adenosine Triphosphate 33%
• Cerebrovascular Disease 33%
• Thromboplastin 33%
• Imidazole 33%